26.07.22
Cannabis Business Times
Changing laws and regulations in countries such as Germany, Switzerland and Spain indicate increased cannabis access for consumers and patients.
22.07.22
Benzinga
Vertical integration in the cannabis industry is one of the most debated topics of the day across the sector.
As part of America’s piecemeal approach to state-level legalization, states can choose their regulations. In most cases, vertical integration is allowed, with some states requiring separate licenses to integrate vertically.
20.07.22
YouTube – International Cannabis Business Conference
Are cannabinoids and other cannabis active ingredients a building block for the biotechnology of the future? What does the future of cannabinoids and other cannabis-derived active ingredients in life science industries hold? Michael will discuss these and other questions with some key industry stakeholders.
18.07.22
Benzinga
Annual cannabis vape sales continue to grow across many major markets–fueling demand and a growing eco-footprint.
Rising consumer demand comes despite environmental concerns lobbed at various market aspects, from cultivation to packaging. Worries are exceptionally high on single-use disposable vaporizers, a surging sector with high waste potential.
13.07.22
The second quarter in Europe far outpaced the first quarter in market movements regarding legislative country news and Merger & Acquisition (M&A) transactions. Europe is currently moving faster than the United States did in 2004 and will likely pick up the pace dramatically as 2023 looks like a boom year for revenues and access.
24.06.22
High Times
A bill to allow financial services to businesses in the legal cannabis industry was dropped from a China competition bill after passing in the House of Representatives but failing to gain the approval of Senate negotiators.
23.06.22
Benzinga
The Swiss government confirmed that it will remove limitations on medical marijuana use, starting August 1st, 2022.
Medical marijuana patients are required to seek exceptional authorization from the health ministry to get medical cannabis prescriptions, which causes needless delays. Starting in August, the decision to use a cannabis-based medicine for therapeutic purposes will be taken by the physician in consultation with the patient, reported Leafie.
22.06.22
Leafie
The Swiss government announced today that it will lift restrictions on cannabis for medical use from August 1st 2022.
Presently, patients have to seek exceptional permission from the health ministry to be prescribed the drug, causing unnecessary delays. The decision to use a cannabis-based medicine for therapeutic purposes will now rest with the doctor, in consultation with the patient.
16.06.22
Benzinga
In the days leading up to the recent bear market entry, cannabis insiders provided Benzinga with varied opinions regarding the impact of inflation on the cannabis sector.
Benzinga
As fears of skyrocketing inflation fueled the bear market, some remained optimistic about cannabis, even confident in some instances.